Skip to main navigation Skip to search Skip to main content

ONE YEAR OF DUODENAL-JEJUNAL BYPASS LINER THERAPY (ENDOBARRIER (R)) LEADS TO SIGNIFICANT CHANGES IN LIVER BIOCHEMISTRY ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE

  • A Ruban
  • , M Glaysher
  • , A Miras
  • , CG Prechtl
  • , AP Goldstone
  • , NA Johnson
  • , M Aldhwayan
  • , N Chhina
  • , W Al-Najim
  • , H Ashrafian
  • , M Patel
  • , J Byrne
  • , JP Teare

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Original languageEnglish
Title of host publicationGASTROINTESTINAL ENDOSCOPY
PagesAB225-AB226
Volume91
Publication statusPublished (in print/issue) - 1 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this